These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6931620)

  • 1. Prediction of response to chemotherapy in acute myelocytic leukemia.
    Preisler HD
    Blood; 1980 Sep; 56(3):361-7. PubMed ID: 6931620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
    Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of cytosine arabinoside on DNA synthesis as predictor for acute myelocytic leukemia (AML) patients' response to chemotherapy.
    Epstein J; Preisler H
    Eur J Cancer (1965); 1981 Jun; 17(6):623-8. PubMed ID: 6946929
    [No Abstract]   [Full Text] [Related]  

  • 4. Prognostic value of clonogenic assay for induction and duration of complete remission in acute myelogenous leukemia.
    Marie JP; Zittoun R; Delmer A; Thevenin D; Suberville AM
    Leukemia; 1987 Feb; 1(2):121-6. PubMed ID: 3478535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of rubidazone and cytosine arabinoside in the treatment of first relapse in acute myelocytic leukemia.
    Pavlovsky S; Fernández I; Palau V; Santarelli MT; De Bellis R; Ruiz-Argüelles G; Brandalise S; Jiménez-Fonseca E
    Ann Oncol; 1991 Jun; 2(6):441-2. PubMed ID: 1768631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
    Malpas J; Mathé G; Hayat M
    Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
    [No Abstract]   [Full Text] [Related]  

  • 7. The effects of exposure to cytosine arabinoside upon the proliferation of leukemia colony forming units in vitro.
    Preisler HD
    Med Pediatr Oncol; 1982; 10 Suppl 1():149-55. PubMed ID: 7162460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
    Gustavsson A; Olofsson T
    Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The effects of cytosine arabinoside and daunomycin on cell kinetics in childhood acute myeloblastic leukemia].
    Tsukimoto I; Toyosaka H; Tashiro Y; Nagao T
    Rinsho Ketsueki; 1973 Jul; 14(7):762-8. PubMed ID: 4517365
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative study of cytosine arabinoside therapy alone and combined with thioguanine, mercaptopurine, or daunorubicin in acute myelocytic leukemia.
    Carey RW; Ribas-Mundo M; Ellison RR; Glidewell O; Lee ST; Cuttner J; Levy RN; Silver R; Blom J; Haurani F; Spurr CL; Harley JB; Kyle R; Moon JH; Eagan RT; Holland JH
    Cancer; 1975 Nov; 36(5):1560-6. PubMed ID: 1059499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adriamycin and cytosine arabinoside contribute equally to prediction of response in acute myelocytic leukemia with improved confidence level.
    Lihou MG; Smith PJ
    Cancer Chemother Pharmacol; 1985; 14(2):116-9. PubMed ID: 3855705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
    Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
    Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial in vitro marrow culture in acute myelocytic leukemia.
    Bull JM; Duttera MJ; Stashick ED; Northup J; Henderson E; Carbone PP
    Blood; 1973 Nov; 42(5):679-86. PubMed ID: 4518061
    [No Abstract]   [Full Text] [Related]  

  • 14. Drug sensitivity test for acute myeloblastic leukemia by an efficient leukemic blast colony assay using 5637-conditioned medium as a stimulator.
    Asano Y; Okamura S; Shibuya T; Morioka E; Harada M; Akazawa K; Niho Y
    J Med; 1990; 21(6):289-99. PubMed ID: 2093096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro drug sensitivity of leukemic progenitors and P-glycoprotein expression in adult acute myeloid leukemia: correlation with induction treatment outcome.
    Basara N; Radosević-Radojković N; Colović M; Bosković D; Rolović Z
    Eur J Haematol; 1995 Aug; 55(2):83-7. PubMed ID: 7628594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-induced kinetic perturbations of the marrow blasts in acute leukemia. Effects of the daunorubicin, cytosine arabinoside and 6-thioguanine combination.
    Amadori S; Petti MC; Mastrovincenzo C; Testa MG
    Acta Haematol; 1979; 61(5):237-42. PubMed ID: 111451
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5).
    Garrido SM; Appelbaum FR; Willman CL; Banker DE
    Exp Hematol; 2001 Apr; 29(4):448-57. PubMed ID: 11301185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug sensitivity of human acute myelocytic leukemia cells (HL-60) and normal human myelocytes (CFU-C) in a co-culture].
    Himori T; Ohnuma T; Wakui A
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1170-8. PubMed ID: 6575724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposomal encapsulation of a synergistic molar ratio of cytarabine and daunorubicin enhances selective toxicity for acute myeloid leukemia progenitors as compared to analogous normal hematopoietic cells.
    Kim HP; Gerhard B; Harasym TO; Mayer LD; Hogge DE
    Exp Hematol; 2011 Jul; 39(7):741-50. PubMed ID: 21530609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.
    Crowther D; Bateman CJ; Vartan CP; Whitehouse JM; Malpas JS; Fairley GH; Scott RB
    Br Med J; 1970 Nov; 4(5734):513-7. PubMed ID: 4921703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.